Organization
Anastasia Vishnevetsky, MD, MPH
1 clinical trial
Clinical trial
A Pilot Randomized Trial of Efgartigimod Alfa for the Treatment of Incident Moderate to Severe Acute Optic NeuritisStatus: Not yet recruiting, Estimated PCD: 2026-12-01
1 clinical trial